Comfort SO, Sayedahmed EE, Wang WC, Suresh R, Schr. Development and evaluation of bovine adenovirus vector-based avian influenza vaccine efficacy in poultry. Poult Sci. 2026 Sep 22;105(12):107833
Avian influenza virus (AIV) remains a persistent threat to global poultry health and production, necessitating the development of novel and effective vaccination strategies. This study evaluated the immunogenicity and protective efficacy of a newly developed bovine adenovirus-vector-based avian influenza virus (BAdV-AIV) vaccine expressing the hemagglutinin (HA) gene of H5N1 and the nucleoprotein (NP) gene of H7N9 AIV subtypes (BAdV - (H5N1)HA+(H7N9)NP). In our study, the candidate vaccine was administered via three mucosal routes: oral (OR), intranasal (IN), or intraocular (IO), using three different doses (10?, 10?, and 10? pfu/bird) in a prime-boost vaccination regimen in broiler chickens. Immunological analyses revealed that high-dose vaccination, administered via the IO route induced a substantial upregulation of virus-specific systemic IgY, hemagglutination inhibition (HI) antibody titers, mucosal sIgA antibody responses in bile, trachea and intestines, and activation of various T-cell subsets (helper T cells, cytotoxic T cells, and γδ T lymphocytes). The quantitative PCR (qPCR) assay failed to detect a difference in the challenge H5N2 AIV genomic equivalent load in the vaccinated groups. A qualitative analysis for live challenge virus detection was performed by inoculating the tracheal swab fluid into embryonated chicken eggs and harvested allantoic fluid was tested by hemagglutination assay. Our data showed a lower percentage of tracheal samples yielding detectable live virus in the high-dose BAdV-(H5N1)HA+H7N9)NP AIV vaccine group, particularly following IO administration, compared with the other vaccination routes. Overall, the BAdV-(H5N1)HA+ (H7N9)NP vaccine elicited AIV-specific humoral, mucosal, and cellular immune responses and was associated with a reduced percentage of virus-isolation-positive tracheal samples, particularly following IO administration. These findings support the need for further evaluation of this vaccine platform for avian influenza control in poultry.
See Also:
Latest articles in those days:
- NDCC Disease Update 5 of 2026 - Avian Influenza 7 hours ago
- Seasonal Dynamics and Genotype Turnover of H5N1 High-Pathogenicity Avian Influenza Viruses in Wild Birds and Crane Roost Water in the Izumi Plain, Japan, 2024/25 2 days ago
- Evolution of Avian Influenza H5N1 strain in Nigeria from 2006 to 2023: Insight from phylogeographic and gene pool analyses 2 days ago
- Susceptibility of seasonal influenza viruses to neuraminidase inhibitors and baloxavir in Qinghai Province, 2021-2025 2 days ago
- Leveraging public data to forecast HPAI spillovers in unusual/new wild hosts 2 days ago
[Go Top] [Close Window]


